New Mexico Educational Retirement Board cut its stake in Cooper Companies Inc (NYSE:COO) by 17.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,150 shares of the medical device company’s stock after selling 650 shares during the period. New Mexico Educational Retirement Board’s holdings in Cooper Companies were worth $868,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in COO. Norges Bank purchased a new position in Cooper Companies in the fourth quarter valued at $153,518,000. Viking Global Investors LP acquired a new stake in shares of Cooper Companies during the first quarter worth about $120,464,000. Amundi Pioneer Asset Management Inc. increased its position in shares of Cooper Companies by 83.5% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 915,089 shares of the medical device company’s stock worth $294,008,000 after purchasing an additional 416,382 shares in the last quarter. Marshall Wace North America L.P. increased its position in shares of Cooper Companies by 56.1% during the fourth quarter. Marshall Wace North America L.P. now owns 813,443 shares of the medical device company’s stock worth $261,352,000 after purchasing an additional 292,238 shares in the last quarter. Finally, Waddell & Reed Financial Inc. increased its position in shares of Cooper Companies by 39,344.6% during the first quarter. Waddell & Reed Financial Inc. now owns 259,151 shares of the medical device company’s stock worth $71,440,000 after purchasing an additional 258,494 shares in the last quarter. Hedge funds and other institutional investors own 88.09% of the company’s stock.

A number of analysts have recently commented on COO shares. Robert W. Baird lifted their target price on Cooper Companies from $345.00 to $357.00 and gave the stock an “outperform” rating in a research report on Friday, March 6th. Raymond James dropped their price target on Cooper Companies from $340.00 to $330.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Stephens boosted their price target on Cooper Companies from $300.00 to $325.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. Wells Fargo & Co dropped their price target on Cooper Companies from $388.00 to $329.00 and set an “overweight” rating on the stock in a research report on Thursday, May 21st. Finally, Jefferies Financial Group dropped their price target on Cooper Companies from $360.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $335.75.

Shares of NYSE:COO opened at $270.93 on Tuesday. The business’s 50 day simple moving average is $299.29 and its 200-day simple moving average is $312.65. The firm has a market capitalization of $14.56 billion, a price-to-earnings ratio of 39.44, a price-to-earnings-growth ratio of 2.81 and a beta of 0.92. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.14 and a quick ratio of 0.58. Cooper Companies Inc has a 12 month low of $236.68 and a 12 month high of $365.68.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.51 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.29 by ($0.78). Cooper Companies had a return on equity of 14.67% and a net margin of 13.50%. The firm had revenue of $524.90 million for the quarter, compared to analysts’ expectations of $604.78 million. During the same period last year, the firm earned $2.94 EPS. Cooper Companies’s revenue was down 19.7% compared to the same quarter last year. On average, equities analysts anticipate that Cooper Companies Inc will post 8.84 earnings per share for the current year.

In other Cooper Companies news, SVP Agostino Ricupati purchased 1,000 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was bought at an average cost of $281.47 per share, for a total transaction of $281,470.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Holly R. Sheffield acquired 880 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were purchased at an average price of $283.18 per share, with a total value of $249,198.40. Following the completion of the acquisition, the executive vice president now owns 930 shares in the company, valued at $263,357.40. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: Stock Market – What is a circuit breaker?

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.